Navigation Links
TGen Drug Development recognized for economic development of Arizona biosciences
Date:9/28/2011

SCOTTSDALE, Ariz. Sept. 28, 2011 TGen Drug Development (TD2) won a Fast Lane award from the Arizona BioIndustry Association (AZBio) for promoting the economic development of Arizona biosciences.

TD2, a subsidiary of the Translational Genomics Research Institute (TGen), provides world-class clinical and regulatory expertise to biopharmaceutical companies using cutting-edge technology to minimize the risks in cancer drug development. TD2 works to shorten the development cycles for anti-cancer agents and improve their success rates.

"TD2 is at the forefront of helping pharmaceutical companies navigate the regulatory system to get the safest, most effective compounds as quickly as possible to the patients who need them," said Dr. Stephen Gately, President and Chief Scientific Officer of TD2. "This award not only recognizes the good work of TD2, but is reflective of all the advancements of TGen, and of our collaborators."

Another recipient of a Fast Lane award is Flagship Biosciences, which provides tissue analysis services. Earlier this year, the Flagstaff company forged a strategic alliance with TD2 to help speed new drugs safely into human testing, where they can quickly benefit cancer patients.

Since 2002, according to Battelle: jobs in Arizona's bioscience industry grew 32 percent; the number of bioscience and related firms including research, manufacturing, testing, medical labs, and healthcare delivery systems grew 28 percent; and research partnerships with the National Institutes of Heath (NIH) increased 65 percent. Arizona bioscience organizations now generate $21 billion in annual revenues and $765 million in state and local taxes.

"These are measurable results from a community committed to working together to build a world-class research base, support commercialization efforts, and migrate the latest discoveries from the bench to the bedside in a manner that is both translational and transformational, " said Joan Koerber-Walker, President and CEO of AZBio. "Organizations like TD2 and their partners ensure that we keep advancing healthcare at an ever increasing rate."

In announcing the Fast Lane awards, the association noted that almost every news article about economic recovery points to two key driving factors, innovation and jobs. "Combining both in a way that is delivering measurable results is Arizona's bioscience sector. Thanks to a coordinated plan developed in 2002 and supported by leaders from Arizona's healthcare industry, corporations, government and universities, Arizona is moving forward faster in economic development, job creation and bioscience research."

TD2 officials will join Arizona scientists and biosciences organizations and businesses at the Arizona BioIndustry Association's AZBio Expo awards gala Oct. 13 at the Sheraton Wild Horse Pass in Chandler, Ariz. For more information about AZBio and the AZBio Awards, please visit www.AZBio.org and www. AZBioExpo.com.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Fast-evolving genes control developmental differences in social insects
2. Report showcases success of integrated development approaches
3. New roles emerge for non-coding RNAs in directing embryonic development
4. Recipients of the 2011 Postdoctoral Professional Development and Enrichment Award
5. Cells derived from pluripotent stem cells are developmentally immature
6. Genomewide mapping reveals developmental and environmental impacts
7. Childhood eye tumor made up of hybrid cells with jumbled development
8. Toronto researchers first to discover new genetic clue in the development of rheumatoid arthritis
9. FASEB MARC program announces the travel award recipients for the 2011 Leadership Development and Grant Writing Seminar for graduate students, postdoctoral fellows and new assistant professors
10. Genetic analysis of amniotic fluid shows promise for monitoring fetal development
11. Novel analysis by Allen Institute sheds new light on the mechanisms of brain development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/4/2017)... , Jan. 4, 2017  CES 2017 – ... sensor technology, today announced the launch of two ... systems, the highly-accurate biometric sensor modules that incorporate ... technology, experience and expertise. The two new designs ... specifically for hearables, and Benchmark BW2.0, a 2-LED ...
(Date:12/22/2016)... 2016 SuperCom (NASDAQ:   ... the e-Government, Public Safety, HealthCare, and Finance sectors announced today that ... selected to implement and deploy a community-based supportive services program to ... , further expanding its presence in the state. ... This new program, which is ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
Breaking Biology News(10 mins):
(Date:1/18/2017)... ... January 18, 2017 , ... Researchers from a new study are stating that if ... after prostate cancer treatment, this indicates there is still remaining prostate cancer cells that are ... The PSA test has always been an indicator of whether a man’s prostate cancer ...
(Date:1/18/2017)... ... January 18, 2017 , ... uBiome, the leading ... by its Science Editor, Dr. Elisabeth Bik, in the December 2016 issue of ... joined uBiome in October 2016 from her previous position at Stanford University School ...
(Date:1/18/2017)... 18, 2017  HUYA Bioscience International, (HUYA), the leader ... pharmaceutical innovations, announced today a strategic collaboration ... Investment Company (referred to as CAS Innovation). The collaboration ... by leading scientists at CAS to meet the medical ... is the first company to have recognized ...
(Date:1/18/2017)...  Market Research Future published a half-cooked research report on Global ... at a CAGR of 12% during the period 2016 to 2022. ... ... cell division without any control. These abnormal cells have the ability ... cells can spread to other parts of the body through the ...
Breaking Biology Technology: